ZURA logo

ZURAZura Bio Ltd - Ordinary Shares - Class A

$3.58
$0.03
(0.84%)
Today
Closed $3.58
$0.07
(1.96%)
After Hours
Updated: 07:20 PM EDT
EarningsAug 13
Mkt Cap$337.24M
Vol723,020.00
News
all
press releases
Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Zura Bio Limited (Nasdaq: ZURA) (Zura or the Company), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious...
Business Wire
News Placeholder
More News
News Placeholder
Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer
Zura Bio Limited (Nasdaq: ZURA) (Zura), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and...
Business Wire
News Placeholder
Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates
Zura Bio Limited (Nasdaq: ZURA) (Zura), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and...
Business Wire
News Placeholder
Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Zura Bio Limited (Nasdaq: ZURA) (Zura or the Company), a clinicalstage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious...
Business Wire
News Placeholder
Zura Bio (ZURA) to Release Earnings on Thursday
Zura Bio (NASDAQ:ZURA) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-zura-bio-limited-stock...
MarketBeat
News Placeholder
Zura Bio (NASDAQ:ZURA) Shares Down 5.3% - Time to Sell?
Zura Bio (NASDAQ:ZURA) Shares Down 5.3% - Here's What Happened...
MarketBeat
News Placeholder
Zura Bio Limited (NASDAQ:ZURA) Given Consensus Rating of "Moderate Buy" by Analysts
Zura Bio Limited (NASDAQ:ZURA - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six brokerages that are currently covering the stock, Marketbeat.com reports. One...
MarketBeat
News Placeholder
Zura Bio (NASDAQ:ZURA) Shares Down 6.5% - Here's What Happened
Zura Bio (NASDAQ:ZURA) Shares Down 6.5% - Here's What Happened...
MarketBeat
News Placeholder
Zura Bio (ZURA) Projected to Post Quarterly Earnings on Wednesday
Zura Bio (NASDAQ:ZURA) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-1-zura-bio-limited-stock...
MarketBeat
News Placeholder
Zura Bio (NASDAQ:ZURA) Price Target Raised to $11.00
Chardan Capital increased their price target on Zura Bio from $10.00 to $11.00 and gave the stock a "buy" rating in a report on Monday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.